In The Press:
US Corporate IP Counsel Hear Latest Updates On Patent System
Intelectual Property Watch talks with Partner Charles Macedo. Read the full article here: US Corporate IP Counsel Hear Latest Updates On Patent System
US Supreme Court addresses patent eligibility of isolated DNA and cDNA in Myriad V
Association for Molecular Pathology v Myriad Genetics, Inc, 133 S Ct 2107 (US 2013) (‘Myriad V’), US Supreme Court, 13 June 2013 Abstract The US Supreme Court unanimously ruled that Myriad Genetics, Inc’s claims to isolated, naturally occurring human DNA sequences are not patent-eligible, but that Myriad’s claims to cDNA, which necessarily includes manipulated DNA […]